Finance and efficiency

Value based pricing could cost the NHS more

By 2010-12-23T14:48:00

pills

The planned new value based pricing system for approving drugs to be funded by the NHS could end up costing the NHS more, the Department of Health’s own impact assessment states.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here